U.S. Covid Vaccines Start to Roll Out for Young Children

Rabu, 22 Juni 2022 | 08:26 WIB
U.S. Covid Vaccines Start to Roll Out for Young Children
[ILUSTRASI. On November 16, 2020, US biotech company Moderna announced a vaccine against COVID-19 that is 94.5% effective. Montreal, November 16, 2020./File Photo]
Reporter: Sumber: Reuters | Editor: Thomas Hadiwinata

KONTAN.CO.ID - WASHINGTON. The United States has begun distributing Covid vaccines for children as young as six months around the country, and availability of the shots will improve in the coming days, according to White House Covid-19 response coordinator Dr. Ashish Jha.

U.S. regulators authorized Moderna Inc's two-dose vaccine for children aged six months to five years and the Pfizer-BioNTech three-shot regimen for children aged six months to four years late last week.

It is unclear how many parents will vaccinate their youngest children.

Just one-in-five parents with children under age five said they intended to vaccinate them "right away" after they become eligible, a survey by the Kaiser Family Foundation published in May showed.

Baca Juga: U.S. Stocks Jump 2% After Recent Selloff; Yen Drops vs Dollar

Only about 29% of children aged five to 11 have been fully vaccinated with the Pfizer-BioNTech vaccine since it was authorized in October, according to U.S. data.

Chinmay Hegde, father of a 14-month old daughter, told Reuters outside Children's National Hospital in Washington that the U.S. authorization was a huge relief. His daughter was the first to be vaccinated at the hospital on Tuesday.

"I feel like we can just now go travel and do our trips without feeling as much stress," he said, mentioning a planned family reunion in Canada in July.

Children who begin their vaccinations with the Pfizer shot this week could receive their third dose the week of Sept. 12 or later. Those who receive a first Moderna shot this week could complete their inoculation as soon as July 19.

Dr. Celine Gounder, an infectious disease specialist and editor-at-large for Public Health at Kaiser Health News, said parents will need to consider a trade-off between the number of shots and risk of side-effects.

Moderna's vaccine uses a larger dose and has a higher likelihood of inducing fever than Pfizer's.

"These are not dangerous side effects and they are manageable with medications like acetaminophen," said Gounder, a former member of President Joe Biden's Covid transition team.

But some parents may feel like "'well, even if it's a three-dose vaccine, it will minimize the risk of fever,'" she said.

Baca Juga: Oil Prices Climb on Market Caution Over Tight Supply

Jha said on Twitter on Monday that the rollout for younger children differed from those for other age groups in that there were no mass vaccination sites, but there would be more inoculations done in doctors' offices.

"Parents are clear they want to vaccinate their littlest ones in familiar settings - doctors offices, pharmacies, health clinics, and children's hospitals," he tweeted.

The vaccines began shipping on Friday and Saturday, Jha said, adding that more doctors' offices and hospitals would begin receiving them on Tuesday and Wednesday of this week.

Not all pharmacies will offer the shots to everyone in this age group. CVS Health Corp will offer shots for children aged 18 months and up, while Walmart Inc and Rite Aid Corp will offer them to those aged 3 and older.

Bagikan

Berita Terbaru

Grup Bakrie Gencar Cari Duit Lewat Rights Issue, Rencana ENRG Dinilai Paling Oke
| Kamis, 16 Juli 2026 | 08:00 WIB

Grup Bakrie Gencar Cari Duit Lewat Rights Issue, Rencana ENRG Dinilai Paling Oke

Investor sebaiknya fokus pada efektivitas penggunaan dana hasil rights issue dalam menyikapi maraknya aksi penerbitan saham baru di BEI.

Aksi Net Sell Asing Tak Kunjung Padam, Simak Rekomendasi Saham Hari Ini
| Kamis, 16 Juli 2026 | 07:52 WIB

Aksi Net Sell Asing Tak Kunjung Padam, Simak Rekomendasi Saham Hari Ini

Sentimen positif terkait penilaian terbaru Standard & Poor's (S&P) terbukti belum mampu menjinakkan aksi net sell. 

Tunggu Arah Kebijakan The Fed, Peluang Penguatan IHSG Mulai Terbatas
| Kamis, 16 Juli 2026 | 07:46 WIB

Tunggu Arah Kebijakan The Fed, Peluang Penguatan IHSG Mulai Terbatas

Kemarin, IHSG naik tipis 0,04% ke level 6.041,97. Sementara itu, investor asing mencatatkan net sell Rp 152,35 miliar.

Peluang Rebound TPIA Pasca Gapai Proyek Baru dan Catat Foreign Net Sell Tertinggi
| Kamis, 16 Juli 2026 | 07:44 WIB

Peluang Rebound TPIA Pasca Gapai Proyek Baru dan Catat Foreign Net Sell Tertinggi

TPIA melalui entitas bisnisnya, PT Chandra Waste Energy terpilih sebagai mitra dalam tender proyek pengolahan sampah menjadi energi listrik (PSEL)

Peran BI Menopang Pasar SBN Kian Besar
| Kamis, 16 Juli 2026 | 07:40 WIB

Peran BI Menopang Pasar SBN Kian Besar

Kepemilikan SBN BI meningkat, memicu kekhawatiran dominasi fiskal berkepanjangan.                        

Dihantui Suku Bunga Tinggi, Saham Properti Masih Lesu
| Kamis, 16 Juli 2026 | 07:32 WIB

Dihantui Suku Bunga Tinggi, Saham Properti Masih Lesu

Meski kinerja keuangan sejumlah emiten masih positif, tekanan suku bunga tinggi membuat saham-saham properti kehilangan daya tarik 

IHSG Menghijau 5 Hari Beruntun, Tapi Asing Masih Catat Net Sell Rp 2,1 Triliun
| Kamis, 16 Juli 2026 | 07:31 WIB

IHSG Menghijau 5 Hari Beruntun, Tapi Asing Masih Catat Net Sell Rp 2,1 Triliun

Absennya foreign inflow bukan alasan valid untuk mendiskreditkan reli karena secara historis memang tidak pernah jadi prasyarat.

Grup Barito Siapkan Aksi Akuisisi Jumbo
| Kamis, 16 Juli 2026 | 07:30 WIB

Grup Barito Siapkan Aksi Akuisisi Jumbo

PT Barito Renewables Energy Tbk (BREN) dikabarkan tengah membidik akuisisi perusahaan panas bumi Filipina senilai US$ 5 miliar

Nilai Tukar Rupiah: Mengapa Menguat Tipis Meski Sentimen Melemah?
| Kamis, 16 Juli 2026 | 07:00 WIB

Nilai Tukar Rupiah: Mengapa Menguat Tipis Meski Sentimen Melemah?

Rupiah menguat tipis hari ini, namun proyeksi defisit APBN Rp 734 triliun bisa jadi sentimen pelemah. Simak analisis lengkapnya.

Menanti Bank Syariah Baru, Pesaing BSI
| Kamis, 16 Juli 2026 | 06:50 WIB

Menanti Bank Syariah Baru, Pesaing BSI

Meski terus bertumbuh, industri perbankan syariah masih didominasi BSI. Kehadiran bank syariah baru sebagai pesaing pun masih sebatas proses

INDEKS BERITA

Terpopuler